In July 2022 the Brazilian Doping Control Authority (ABCD) reported an anti-doping rule violation against the weightlifter after his sample tested positive for the prohibited substance Stanozolol.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).
The Athlete could not explain the positive test result and complained that he was hampered in his effort to find the source of the prohibited substance. He requested to lift the provisional suspension and for annulment of the proceedings against him.
He alleged that irregularities in the Laboratory or during the chain of custody had caused the positive test result. Moreover he complained that analysis of his B sample was not possible because he could not attend the opening of the B sample, nor afford the costs of analysis of his B sample and his supplements.
Preliminary the Rapporteur determines that there were no grounds to lift the imposed provisional suspension whereas the test results were deemed to be valid. Because the Doping Control Officer had listed the wrong location of the sample collection, he had rectified this in a supplementary report.
The Rapporteur finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
The Rapporteur concludes that the Athlete failed to demonstrate with corroborating evidence that the violation was not intentional, nor how the substance had entered his system.
Further the Rapporteur considers that the weightlifter is an experienced international level athlete and that had receive anti-doping education. Finally he established that there had been delays in the proceedings not attributed to the Athlete.
Therefore the TJD-AD Panel decides on 3 May 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 5 June 2022.
